Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 760 of 1,261

  1. US 8992989

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  2. US 8992943

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  3. US 8992894

    Oral stain remover and oral composition

    Regenetiss, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  4. US 8992886

    Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

    The Board of Regents of the University of Texas System · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  5. US 8993752

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  6. US 8993768

    Tropolone compounds for treating or preventing retroviral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  7. US 8993758

    Substituted quinoxalines and uses thereof

    The Board of Regents of the University of Texas System · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  8. US 8993719

    Methods and compositions related to mutant Kunitz domain I of TFPI-2

    The Regents of the University of California · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  9. US 8993746

    Nuclease resistant double-stranded ribonucleic acid

    Alnylam Pharmaceuticals, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  10. US 8993626

    Methods of treatment using sterculic acid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  11. US 8993627

    N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

    SENTIENT LIFESCIENCES, INC. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  12. US 8993623

    Method for lowering cholesterol

    Phenomenome Discoveries Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  13. US 8993598

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  14. US 8993600

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  15. US 8993552

    Compositions and methods for treatment of leukemia

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  16. US 8993251

    Genes from 20q13 amplicon and their uses

    The Regents of the University of California · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  17. US 8993117

    Devices with multiple surface functionality

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  18. US 8993519

    Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  19. US 8993266

    Proproteins activatable interferon alpha

    CytomX Therapeutics, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  20. US 8992944

    Purified Plasmodium and vaccine composition

    Sanaria Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  21. US 8992930

    Extracellular IFI16 as therapeutic agents

    University of Piemonte Orientale · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  22. US 8992906

    Compositions and methods for engraftment and increasing survival of adult muscle stem cells

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  23. US 8987377

    Poly(amide) polymers for the delivery of oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  24. US 8989847

    Method of measuring propulsion in lymphatic structures

    The Board of Regents of the University of Texas System · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.